Sumitomo Chemical Company (4005) Q2 2025 earnings summary

Executive summary

• Core operating income achieved a V-shaped recovery, up over ¥120 billion year-on-year, led by IT-related Chemicals and Pharmaceuticals, with net loss of ¥6.5 billion due to FX and Petro Rabigh-related one-offs; sales revenue for H1 FY2024 rose 4.6% to ¥1,241.4 billion.

• FY2024 full-year forecast: core operating income ¥100 billion, net income ¥25 billion, both up from previous guidance, despite one-off losses.

• Accelerated business portfolio upgrade, cash generation target raised to ¥700 billion, and interest-bearing liabilities to be reduced by ¥300 billion.

• Structural reforms progressing, including cost reductions and sales expansion in Pharma, operational optimization in petrochemicals, and launch of a new 4-segment organization in October 2024.

• Interim dividend of ¥3 per share declared, with annual DPS maintained at ¥9.

Financial highlights

• H1 FY2024 sales revenue was ¥1,241.4 billion, core operating income ¥29.5 billion, net loss attributable to owners ¥6.5 billion, a significant improvement from the prior year.

• Core operating income improved by ¥126.1 billion year-on-year; all segments showed improvement.

• IT-related Chemicals income up ¥19.7 billion year-on-year to ¥37.5 billion, a record high for the first half.

• Health and Crop Sciences improved due to methionine market recovery, increased crop protection shipments, and yen depreciation.

• Full-year forecast: sales revenue ¥2,600 billion, core operating income ¥100 billion, net income ¥25 billion, including a ¥46 billion one-off loss.

Outlook and guidance

• FY2024 core operating income expected to reach ¥100 billion, with similar target for FY2025 based on actual performance.

• Cash generation target increased to ¥700 billion, with ongoing business portfolio upgrades and selective investments.

• Dividend forecast maintained at ¥9 per share, prioritizing financial position strengthening; aim for ¥24/share or more per year in the future.

• Long-term goal to achieve core operating income of ¥100 billion in FY2025 without one-off gains.